video
Video: ASMS 2019: timsTOF fleX – MALDI Guided SpatialOMx
Combining the world's fastest proteomics instrument with over 25 years of MALDI experience.
List view / Grid view
Proteomics
Filter the results
video
Video: ASMS 2019: diaPASEF
The timsTOF Pro with diaPASEF enables deeper proteome coverage in a single 4D shotgun proteomics experiment, with highly reproducible qualitative and quantitative results - making it a near-ideal mass analyzer for proteomics.
Whitepapers/App Notes/Posters
Scientific poster: High-throughput proteome analysis using 50 cm micro pillar array columns (μPAC™)
The practice of bottom-up proteomics relies to a large extent on the separation performance that can be achieved with state-of-the art nano LC-MS/MS equipment.
article
Scientific Poster & Whitepaper Gallery 2019
The latest research and developments from Pharma and Biopharma industry experts.
article
Open data policies in proteomics are starting to revolutionise the field
High-throughput mass spectrometry (MS)-based proteomics approaches have developed enormously in recent years and are continuing to do so. The current trend sees proteomics being used by academia and industry to tackle intricate biological questions, often in conjunction with other high-throughput “omics” disciplines such as genomics, transcriptomics and metabolomics. Within the…
article
Mass Spectrometry In-Depth Focus 2019
In this issue: identification of peptides and proteins in suspected illegal medicinal products using MALDI-TOF-MS, and open data policies in proteomics.
news
Protein map using MS-based analysis shared in open database
Study using mass spectrometry-based analysis provides a greater understanding of the cell and a comprehensive map of cell proteins...
webinar
Quality assessment of biologics: higher order structure analysis using NMR
27 July 2018 | By Bruker
The webinar describes how 2D NMR can offer protein biochemists unprecedented analytical precision. By assigning just one spectrum, users can obtain a unique fingerprint of a protein at an atomistic resolution. This non-destructive technique can also be combined with other complimentary techniques to gain even further insights into sample quality.…
news
Thermo Fisher Scientific opens U.S. Precision Medicine Science Center
Supports development of analytical workflows to generate precise molecular profiles of patients...
news
Bruker introduces scimaX™ MRMS for novel phenomics workflows, and further enhances the timsTOF™ Pro for PASEF Proteomics at ASMS
At the 66th ASMS Conference, Bruker announces innovative mass spectrometry products and workflows for breakthroughs in life-science research, in clinical research and large-cohort validations in phenomics and proteomics, in novel biopharma applications and in applied toxicology and forensics markets...
news
Thermo Scientific and Evosep collaborate to develop and promote robust, high-throughput workflows for clinical proteomics
Today, at the 66th Conference on Mass Spectrometry and Allied Topics, Thermo Scientific and Evosep announced a joint effort to develop and promote robust, high-throughput workflows for clinical proteomics...
news
GlycoSCORES technique accelerates protein therapy research
Researchers have developed a new biotech technique that promises to accelerate research into protein therapies...
news
Machine learning may reveal cause-effect relationships in protein dynamics data
A group of researchers is showing how artificial intelligence approaches can help identify cause-effect relationships within data...
news
Novel methodology increases resolution in oligodendrocyte proteomics
Brazilian researchers combine mass spectrometry, 2-D liquid chromatography and ion mobility to identify over 10,000 proteins in brain cells possibly involved in schizophrenia.
article
The future of bioanalysis with microchip chromatography
Much rests on the further development of bioanalytical technologies which allow the highest level of sensitivity on small samples, and robust, high reproducibility across large populations. Johan Devenyns, CEO PharmaFluidics, explains further...